Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia

Neurology

Volumn 68, Issue 12, 2007, Pages 927-931

  Kovari E ^a,e   Gold, G ^a,d   Herrmann, F R ^a   Canuto, A ^a   Hof, P R ^c   Bouras, C ^a,c   Giannakopoulos, P ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b University of Lausanne Medical Center   (Switzerland)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Hopital de Geriatrie   (Switzerland)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN REGION; CLINICAL DEMENTIA RATING SCALE; COGNITION; CONTROLLED STUDY; DEMENTIA; DEMYELINATING DISEASE; FEMALE; GLIOSIS; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MALE; MENTAL DETERIORATION; MULTIVARIATE ANALYSIS; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; RATING SCALE; STATISTICAL MODEL; UNIVARIATE ANALYSIS; VASCULAR DISEASE; WHITE MATTER;

AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBRAL CORTEX; CEREBRAL INFARCTION; COGNITION DISORDERS; DEMENTIA; DEMYELINATING DISEASES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MICROCIRCULATION; MULTIVARIATE ANALYSIS; NERVE FIBERS, MYELINATED; NEUROFIBRILLARY TANGLES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SENILE PLAQUES;

EID: 34147092550     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000257094.10655.9a     Document Type: Article

References (46)

1. Del Ser T, Bermejo F, Portera A, Arredondo JM, Bouras C, Constantinidis J. Vascular dementia. A clinicopathological study. J Neurol Sci 1990;96:1-17.
2. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and postmortem neuropathological study. J Neurol Neurosurg Psychiatry 1988;51:1037-1044.
3. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813-817.
4. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11:205-242.
5. Chukwudelunzu FE, Meschia JF, Graff-Radford NR, Lucas JA. Extensive metabolic and neuropsychological abnormalities associated with discrete infarction of the genu of the internal capsule. J Neurol Neurosurg Psychiatry 2001;71:658-662.
6. Erkinjuntti T. Subcortical vascular dementia. Cerebrovasc Dis 2002;13(suppl 2):58-60.
7. Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm (Suppl) 2000;59:23-30.
8. Kramer JH, Reed BR, Mungas D, Weiner MW, Chui HC. Executive dysfunction in subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2002;72:217-220.
9. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol 2002;1:426-436.
10. Gold G, Kövari E, Herrmann FR, et al. Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke 2005;36:1184-1188.
11. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study. Neurology 2001;56:1539-1545.
12. de Groot JC, de Leeuw FE, Oudkerk M, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002;52:335-341.
13. Esiri MM. Which vascular lesions are of importance in vascular dementia? Ann NY Acad Sci 2000;903:239-243.
14. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999;354:919-920.
15. Kövari E, Gold G, Herrmann FR, et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004;35:410-414.
16. Vinters HV, Ellis WG, Zarow C, et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 2000;59:931-945.
17. Bracco L, Campani D, Baratti E, et al. Relation between MRI features and dementia in cerebrovascular disease patients with leukoaraiosis: a longitudinal study. J Neurol Sci 1993;120:131-136.
18. Burns JM, Church JA, Johnson DK, et al. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease. Arch Neurol 2005;62:1870-1876.
19. Longstreth WT Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274-1282.
20. Ylikoski A, Erkinjuntti T, Raininko R, Sarna S, Sulkava R, Tilvis R. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995;26:1171-1177.
21. Rossler M, Zarski R, Bohl J, Ohm TG. Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuropathol (Berl) 2002;103:363-369.
22. Gold G, Bouras C, Kövari E, et al. Clinical validity of Braak neuropathological staging in the oldest-old. Acta Neuropathol (Berl) 2000;99:579-582.
23. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
24. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-259.
25. Vallet PG, Guntern R, Hof PR, et al. A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol 1992;83:170-178.
26. Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody at8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995;189:167-169.
27. Bussière T, Friend PD, Sadeghi N, et al. Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience 2002;112:75-91.
28. Thal DR, Rüb U, Schultz C, et al. Sequence of abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 2000;59:733-748.
29. Miklossy J. Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease. Neurol Res 2003;25:605-610.
30. Suter OC, Sunthorn T, Kraftsik R, et al. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 2002;33:1986-1992.
31. Purandare N, Burns A, Daly KJ, et al. Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: case-control study. Br Med J 2006;332:1119-1124.
32. Golomb J, Kluger A, Gianutsos J, Ferris SH, de Leon MJ, George AE. Nonspecific leukoencephalopathy associated with aging. Neuroimaging Clin North Am 1995;5:33-44.
33. Sahlas DJ, Bilbao JM, Swartz RH, Black SE. Clasmatodendrosis correlating with periventricular hyperintensity in mixed dementia. Ann Neurol 2002;52:378-381.
34. Udaka F, Sawada H, Kameyama M. White matter lesions and dementia: MRI-pathological correlation. Ann NY Acad Sci 2002;977:411-415.
35. Damian MS, Schilling G, Bachmann G, Simon C, Stoppler S, Dorndorf W. White matter lesions and cognitive deficits: relevance of lesion pattern? Acta Neurol Scand 1994;90:430-436.
36. Tanabe JL, Ezekiel F, Jagust WJ, et al. Magnetization transfer ratio of white matter hyperintensities in subcortical ischemic vascular dementia. AJNR Am J Neuroradiol 1999;20:839-844.
37. van Gijn J. Leukoaraiosis and vascular dementia. Neurology 1998;51:S3-S8.
38. Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999;67:66-72.
39. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47:145-151.
40. Garde E, Mortensen EL, Krabbe K, Rostrup E, Larsson HB. Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet 2000;356:628-634.
41. Del Ser T, Hachinski V, Merskey H, Munoz DG. Alzheimer's disease with and without cerebral infarcts. J Neurol Sci 2005;231:3-11.
42. Jellinger KA. Understanding the pathology of vascular cognitive impairment. J Neurol Sci 2005;229-230:57-63.
43. Nagy Z, Esiri MM, Jobst KA, et al. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 1997;56:165-170.
44. Zekry D, Duyckaerts C, Moulias R, et al. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol (Berl) 2002;103:481-487.
45. Giannakopoulos P, Herrmann FR, Bussière T, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003;60:1495-1500.
46. Bouras C, Kövari E, Herrmann F, et al. Stereologic analysis of microvascular morphology in the elderly: Relationships with Alzheimer's disease pathology and cognitive status. J Neuropathol Exp Neurol 2006;65:235-244.